CODX
Price:
$0.7291
Market Cap:
$23.28M
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify gen...[Read more]
Industry
Medical - Devices
IPO Date
2017-07-12
Stock Exchange
NASDAQ
Ticker
CODX
According to Co-Diagnostics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.92. This represents a change of -25.24% compared to the average of 9.25 of the last 4 quarters.
The mean historical Current Ratio of Co-Diagnostics, Inc. over the last ten years is 7.37. The current 6.92 Current Ratio has changed 9.28% with respect to the historical average. Over the past ten years (40 quarters), CODX's Current Ratio was at its highest in in the September 2020 quarter at 28.63. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
7.37
Median
5.96
Minimum
0.15
Maximum
23.94
Discovering the peaks and valleys of Co-Diagnostics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.15%
Maximum Annual Current Ratio = 23.94
Minimum Annual Increase = -93.69%
Minimum Annual Current Ratio = 0.15
Year | Current Ratio | Change |
---|---|---|
2023 | 10.81 | -54.84% |
2022 | 23.94 | 161.99% |
2021 | 9.14 | -39.70% |
2020 | 15.16 | 213.84% |
2019 | 4.83 | 979.72% |
2018 | 0.45 | -93.69% |
2017 | 7.09 | 2.15% |
2016 | 0.31 | 105.75% |
2015 | 0.15 | -91.68% |
The current Current Ratio of Co-Diagnostics, Inc. (CODX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.63
5-year avg
12.78
10-year avg
7.37
Co-Diagnostics, Inc.’s Current Ratio is greater than Heart Test Laboratories, Inc. (1.72), greater than NanoVibronix, Inc. (1.74), greater than Rapid Micro Biosystems, Inc. (5.52), greater than ThermoGenesis Holdings, Inc. (0.52), greater than Biomerica, Inc. (3.00), greater than Nemaura Medical Inc. (0.19), greater than Bluejay Diagnostics, Inc. (6.26), greater than Movano Inc. (3.31), less than INVO Bioscience, Inc. (0), less than enVVeno Medical Corporation (22.01), greater than Tivic Health Systems, Inc. (5.65), less than Bone Biologics Corporation (14.87), greater than Vivos Therapeutics, Inc. (1.44), greater than Senseonics Holdings, Inc. (2.47), greater than Inogen, Inc. (2.66), greater than ClearPoint Neuro, Inc. (4.54), greater than NeuroPace, Inc. (5.59), greater than Surmodics, Inc. (3.96), less than CVRx, Inc. (11.32), less than NeuroMetrix, Inc. (13.88), greater than ReShape Lifesciences Inc. (1.33), greater than Inspira Technologies Oxy B.H.N. Ltd. (2.61), greater than OpGen, Inc. (5.46),
Company | Current Ratio | Market cap |
---|---|---|
1.72 | $3.63M | |
1.74 | $2.03M | |
5.52 | $39.24M | |
0.52 | $9.51K | |
3.00 | $4.58M | |
0.19 | $8.07K | |
6.26 | $2.01M | |
3.31 | $37.11M | |
0 | $3.25M | |
22.01 | $51.03M | |
5.65 | $1.85M | |
14.87 | $2.43M | |
1.44 | $24.76M | |
2.47 | $281.59M | |
2.66 | $200.79M | |
4.54 | $403.56M | |
5.59 | $341.46M | |
3.96 | $564.90M | |
11.32 | $303.30M | |
13.88 | $8.07M | |
1.33 | $3.04M | |
2.61 | $21.29M | |
5.46 | $7.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Co-Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Co-Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Co-Diagnostics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Co-Diagnostics, Inc. (CODX)?
What is the highest Current Ratio for Co-Diagnostics, Inc. (CODX)?
What is the 3-year average Current Ratio for Co-Diagnostics, Inc. (CODX)?
What is the 5-year average Current Ratio for Co-Diagnostics, Inc. (CODX)?
How does the current Current Ratio for Co-Diagnostics, Inc. (CODX) compare to its historical average?